135 related articles for article (PubMed ID: 35531461)
1. The efficacy of recombinant tissue plasminogen activator in severe post-operative fibrinous reaction after uneventful phacoemulsification - a case series and review.
Ibramsah AB; Cheong AI; Wan Muda WN; Ibrahim M
Rom J Ophthalmol; 2022; 66(1):27-31. PubMed ID: 35531461
[No Abstract] [Full Text] [Related]
2. Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery.
Ozveren F; Eltutar K
J Cataract Refract Surg; 2004 Aug; 30(8):1727-31. PubMed ID: 15313298
[TBL] [Abstract][Full Text] [Related]
3. Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery.
Osaadon P; Belfair N; Lavy I; Walter E; Levy J; Tuuminen R; Achiron A; Knyazer B
Eur J Ophthalmol; 2022 Jan; 32(1):200-204. PubMed ID: 33719630
[TBL] [Abstract][Full Text] [Related]
4. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
Klais CM; Hattenbach LO; Steinkamp GW; Zubcov AA; Kohnen T
J Cataract Refract Surg; 1999 Mar; 25(3):357-62. PubMed ID: 10079440
[TBL] [Abstract][Full Text] [Related]
5. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA
Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
[TBL] [Abstract][Full Text] [Related]
6. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.
Heiligenhaus A; Steinmetz B; Lapuente R; Krallmann P; Althaus C; Steinkamp WK; Dick B
Br J Ophthalmol; 1998 Jul; 82(7):810-5. PubMed ID: 9924378
[TBL] [Abstract][Full Text] [Related]
7. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.
Siatiri H; Beheshtnezhad AH; Asghari H; Siatiri N; Moghimi S; Piri N
Br J Ophthalmol; 2005 Nov; 89(11):1458-61. PubMed ID: 16234453
[TBL] [Abstract][Full Text] [Related]
8. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.
Wedrich A; Menapace R; Ries E; Polzer I
J Cataract Refract Surg; 1997; 23(6):873-7. PubMed ID: 9292671
[TBL] [Abstract][Full Text] [Related]
9. Fibrin reaction after uveitic cataract surgery: treatment and prevention.
da Rocha Lima B; Pichi F; Nucci P; Srivastava SK; Lowder CY
Eur J Ophthalmol; 2014; 24(4):626-8. PubMed ID: 24519510
[TBL] [Abstract][Full Text] [Related]
10. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery.
Wedrich A; Menapace R; Mühlbauer-Ries E
Int Ophthalmol; 1994-1995; 18(5):277-80. PubMed ID: 7607808
[TBL] [Abstract][Full Text] [Related]
11. Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report.
Yoshino H; Seki M; Ueda J; Yoshino T; Fukuchi T; Abe H
BMC Ophthalmol; 2012 Mar; 12():3. PubMed ID: 22433746
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant tissue plasminogen activator (rTPA) for treatment of fibrin in the anterior chamber of the horse.
Pereira R; Bowen M; Rapezzano G; Redpath A; Pratt S; Hallowell G
Vet Med Sci; 2024 Jul; 10(4):e1448. PubMed ID: 38818763
[TBL] [Abstract][Full Text] [Related]
13. [Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery].
Oficjalska-Młyńczak J; Marek J; Zajac-Pytrus H; Nizankowska MH; Koziorowska M
Klin Oczna; 1996; 98(6):423-5. PubMed ID: 9340414
[TBL] [Abstract][Full Text] [Related]
14. Topical dilation as first-line treatment for fibrin membrane pupillary-block glaucoma following uncomplicated cataract surgery.
Bennett S; Studsgaard A; Telinius N
BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37072300
[TBL] [Abstract][Full Text] [Related]
15. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
Schmitz K; Greite JH; Bartenschlager EM
Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
[TBL] [Abstract][Full Text] [Related]
17. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome.
Dotan A; Kaiserman I; Kremer I; Ehrlich R; Bahar I
Br J Ophthalmol; 2014 Feb; 98(2):252-5. PubMed ID: 24276695
[TBL] [Abstract][Full Text] [Related]
18. Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery.
Fung SS; Sykakis E; Islam NM; Zambarakji HJ; Khoramnia R; Auffarth GU; Parmar DN
J Ophthalmol; 2015; 2015():975075. PubMed ID: 25861464
[TBL] [Abstract][Full Text] [Related]
19. The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007-2012).
Tomlinson JE; Byrne E; Pusterla N; Magdesian KG; Hilton HG; McGorum B; Davis E; Schoster A; Arroyo L; Dunkel B; Carslake H; Boston RC; Johnson AL
J Vet Intern Med; 2015; 29(5):1403-9. PubMed ID: 26256909
[TBL] [Abstract][Full Text] [Related]
20. [Success and complications of rTPA treatment of the anterior eye segment].
Löffler KU; Meyer JH; Wollensak G; Funk J
Ophthalmologe; 1997 Jan; 94(1):50-2. PubMed ID: 9132130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
